| Title : (R)-8-(3-amino-piperidin-1-yl)-7-but-2-ynyl-3-methyl-1-(4-methyl-quinazolin-2-ylm ethyl)-3,7-dihydro-purine-2,6-dione (BI 1356), a novel xanthine-based dipeptidyl peptidase 4 inhibitor, has a superior potency and longer duration of action compared with other dipeptidyl peptidase-4 inhibitors - Thomas_2008_J.Pharmacol.Exp.Ther_325_175 |
| Author(s) : Thomas L , Eckhardt M , Langkopf E , Tadayyon M , Himmelsbach F , Mark M |
| Ref : Journal of Pharmacology & Experimental Therapeutics , 325 :175 , 2008 |
| Abstract : Thomas_2008_J.Pharmacol.Exp.Ther_325_175 |
| ESTHER : Thomas_2008_J.Pharmacol.Exp.Ther_325_175 |
| PubMedSearch : Thomas_2008_J.Pharmacol.Exp.Ther_325_175 |
| PubMedID: 18223196 |
Thomas L, Eckhardt M, Langkopf E, Tadayyon M, Himmelsbach F, Mark M (2008)
(R)-8-(3-amino-piperidin-1-yl)-7-but-2-ynyl-3-methyl-1-(4-methyl-quinazolin-2-ylm ethyl)-3,7-dihydro-purine-2,6-dione (BI 1356), a novel xanthine-based dipeptidyl peptidase 4 inhibitor, has a superior potency and longer duration of action compared with other dipeptidyl peptidase-4 inhibitors
Journal of Pharmacology & Experimental Therapeutics
325 :175
Thomas L, Eckhardt M, Langkopf E, Tadayyon M, Himmelsbach F, Mark M (2008)
Journal of Pharmacology & Experimental Therapeutics
325 :175